MET and hepatocellular carcinoma: This study sheds the light on the activation of the HGF/c-Met/Akt signaling pathway via HCC-cell derived exosomes resulting in the inhibition of Sorafenib-induced apoptosis, thus emphasizing the role of exosomes in Sorafenib resistance in liver cancer [68].